250mg of Medobar i.e. Dobasic Hydrazide Tablets, requires 50mg of Tazodar i.e. Pibedil Extended-Release Tablets is usually referred to as a treatment regimen for Parkinson’s Disease, and the two are used in proportion to each other to enhance the effectiveness of the treatment of Parkinson’s with tremor.
1. Dobazepine tablets are a combination of levodopa and benserazide, in which levodopa is a precursor drug for dopamine and benserazide inhibits dopamine decarboxylase in the body.
2. Parkinson’s patients have insufficient dopamine in the basal ganglia, which leads to muscle weakness, tremor and other symptoms, taking Dobasic Hydrazide tablets can increase the concentration of dopamine, which is mainly used in the treatment of Parkinson’s syndrome.
3. Pibedil extended-release tablets, the main ingredient of pibedil, is a dopamine agonist, can improve the sensitivity of dopamine receptors in the brain, improve the utilization of dopamine, commonly used in the treatment of Alzheimer’s disease, Parkinson’s disease, and Dobazepine tablets used in conjunction with the function of the two complement each other to improve the therapeutic effect.
250mg Medoxomil requires 50mg Tessuta is a clinical experience use. However, the Parkinson’s medication regimen needs to be specifically adjusted according to the clinical situation, and should be treated under the guidance of a professional doctor, do not take medication or change the dosage without authorization.